Daniel Fowler, PhD’s Post

View profile for Daniel Fowler, PhD, graphic

Cannabis Science and Genetics 🧬 Co-Founder and CSO, S3 🧬 Gene Editing 🧬 BetterCannabisThroughScience Consulting 🧬 Molecular Biologist 🧬 Outdoors Enthusiast

"Trust me, bro, the DEA said they don't care about intoxicating hemp derivatives." Oh yeah? Then why are they studying their cannabimimetic effects? That's right, 3 DEA agents listed as co-authors with the research contractor RTI International on this paper, which looked at cannabimimetic effects of minor cannabinoids and synthetic IHDs Δ8-tetrahydrocannabinol (Δ8-THC) and (6aR,9R)-Δ10-tetrahydrocannabinol. I'm not suggesting this is a conspiracy theory. It's well known the DEA is interested in IHDs. But what could this mean for future policy from the DEA? "Delineation of their potential adverse effects, including their ability to produce Δ9-THC-like intoxication, is crucial" "Δ8-THC was the only compound that produced Δ9-THC-like psychoactive effects." And on a side note, despite prior research showing beta-caryophyllene activates CB2 (albeit in the high micromolar range), they claimed "beta-caryophyllene and beta-caryophyllene oxide exhibited negligible affinity for both CB1 and CB2 receptors" #BetterCannabisThroughScience

  • No alternative text description for this image
Daniel Fowler, PhD

Cannabis Science and Genetics 🧬 Co-Founder and CSO, S3 🧬 Gene Editing 🧬 BetterCannabisThroughScience Consulting 🧬 Molecular Biologist 🧬 Outdoors Enthusiast

6mo

Evaluation of cannabimimetic effects of selected minor cannabinoids and Terpenoids in mice Behind a paywall, DM me https://www.sciencedirect.com/science/article/abs/pii/S0278584624000526?via%3Dihub

If I had known the DEA was conducting this type of research, would have applied for a research position years ago.

Johnny Broadcast

Cannabis healer/cancer survivor using RSO/CBD/Cannabinoid therapies. TheAnointedOne.com is a Cannabis consultation/educational/charitable organization helping those "in need" to help, and heal, themselves.

6mo

IHD?? (Intoxicating Hemp Derivatives) HDC?? (Hemp Derived Cannabinoids) Any more?? Can we choose ONE and all stick with it?? 🤣😂

Interesting to see people still abusing poor mice even though we know all studies on lab rats are invalid.

Shannon Moore

President of sales at Shaman Botanicals

6mo

You should be more worried about fentanyl in the US? And the dea

Karyemaître Aliffe, MD

FORWARD-LOOKING, HARVARD-STANFORD, MULTILINGUAL EXECUTIVE PHYSICIAN-SCIENTIST ENTREPRENEUR Translating Breakthrough Science and Real-World Evidence Into Actionable Big Data to Advance Global Human Health Equity

6mo

Mice…🐁🐀🐁🤷♂️

David Heldreth

Patented Inventor (multiple others pending) - CEO, Research Leader and Educational Consultant for medicinal plants w/ special emphasis in cannabis and psychedelics

6mo

I find this ironic - Conflict of interest statement Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Dr Geoff Cutter

Australian Medicinal Cannabis physician at Metamorphosis HealthSpan Clinic

6mo

#DanielFowler. The date on the paper is “8 June 2024” ?! Getting a little ahead of themselves in more than one way??

Blair Curless

Pharmacogenomics | Functional Medicine | Coaching Pharmacists about Cannabis

6mo

Good find and thanks for sharing this.

Davið Pittman

Ingredient Mfg - Plantrolatum™ Technology - Cannabinoid Bioscience R&D - Product Development

5mo

Thanks for sharing… unfortunately their research is flawed and inaccurate on multiple fronts.

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics